|
Apr 5
|
China announces retaliatory tariffs, U.S. unemployment rises: Morning Buzz
|
|
Apr 5
|
2 Dividend Stocks to Buy Hand Over Fist in April
|
|
Apr 5
|
From Ray-Bans to Wigs, US Buyers May See Unexpected Price Hikes
|
|
Apr 3
|
AbbVie (ABBV) Stock Moves -1.73%: What You Should Know
|
|
Apr 3
|
AbbVie cuts 2025 profit forecast on acquisition expenses
|
|
Apr 3
|
3 High-Yielding Dividend Stocks That Retirees Can Buy and Forget About
|
|
Apr 2
|
AbbVie Stock Rises 16% Year to Date: Time to Buy, Sell or Hold?
|
|
Feb 17
|
Why AbbVie Inc. (ABBV) Is One of the Best Drug Stocks to Buy Now
|
|
Feb 16
|
AbbVie Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 15
|
Is AbbVie Stock a Buy Now?
|
|
Feb 14
|
Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs
|
|
Feb 14
|
AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors
|
|
Feb 13
|
AbbVie Declares Quarterly Dividend
|
|
Feb 13
|
AbbVie Inc. (ABBV): Among Lee Munder Capital Group’s Top Stock Picks
|
|
Feb 13
|
Neumora shakes up its C-suite; Biogen cuts early-stage pipeline
|
|
Feb 13
|
Is AbbVie Inc. (NYSE:ABBV) Trading At A 47% Discount?
|
|
Feb 13
|
AbbVie and Xilio to collaborate on antibody-based immunotherapies
|
|
Feb 12
|
Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday?
|
|
Feb 12
|
Allergan Aesthetics To Launch Three New State-of-the-Art Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training
|
|
Feb 12
|
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
|